Barriers to the delivery of diabetes care in the Middle East and South Africa: A survey of 1,082 practising physicians in five countries

International Journal of Clinical Practice

Volumn 67, Issue 11, 2013, Pages 1144-1150

  Assaad Khalil, S H ^a   Al Arouj, M ^b   Almaatouq, M ^c   Amod, A ^d   Assaad, S N ^a   Azar, S T ^e   Belkhadir, J ^f   Esmat, K ^g   Hassoun, A A K ^h   Jarrah, N ⁱ   Zatari, S ^j   Alberti, K G M M ^k  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b DASMAN DIABETES INSTITUTE   (Kuwait)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f National Coordinator of Moroccan Guidelines of Diabetes   (Morocco)

^g Merck Serono Dubai United Arab Emirates ^*  (United Arab Emirates)

^h Dubai   (United Arab Emirates)

ⁱ MUTAH UNIVERSITY   (Jordan)

^j AL HADA ARMED FORCES HOSPITAL   (Saudi Arabia)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; METFORMIN; SULFONYLUREA;

ARTICLE; CONTINUING EDUCATION; CONTROLLED STUDY; DEVELOPING COUNTRY; EGYPT; GLUCOSE BLOOD LEVEL; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LEBANON; LIFESTYLE MODIFICATION; MEDICATION COMPLIANCE; MIDDLE EAST; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SAUDI ARABIA; SOUTH AFRICA; UNITED ARAB EMIRATES;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; DELIVERY OF HEALTH CARE; DIABETES MELLITUS, TYPE 2; EDUCATION, MEDICAL; HUMANS; HYPOGLYCEMIC AGENTS; MIDDLE EAST; PERCEPTION; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; QUESTIONNAIRES; SOUTH AFRICA;

EID: 84886649332     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12205     Document Type: Article

References (22)

1. International Diabetes Federation. E-atlas of Diabetes, 5th edn. http://www.eatlas.idf.org (accessed May 2013).
2. Al-Maatouq M, Al-Arouj M, Assaad SH, et al. Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin. Int J Clin Pract 2010; 64: 149-59.
3. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36 (Suppl 1): S11-66.
4. Zgibor JC, Songer TJ,. External barriers to diabetes care: addressing personal and health systems issues. Diabetes Spectrum 2001; 14: 23-9.
5. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL,. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract 2011; 93: 1-9.
6. Reed RL, Revel AO, Carter A, Saadi HF, Dunn EV,. A clinical trial of chronic care diabetic clinics in general practice in the United Arab Emirates: a preliminary analysis. Arch Physiol Biochem 2001; 109: 272-80.
7. Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M,. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011; 16: 43-9.
8. Lamchahab FZ, El Kihal N, Khoudri I, Chraibi A, Hassam B, Ait Ourhroui M,. Factors influencing the awareness of diabetic foot risks. Ann Phys Rehabil Med 2011; 54: 359-65.
9. Soliman AR, Fathy A, Roshd D,. The growing burden of end-stage renal disease in Egypt. Ren Fail 2012; 34: 425-8.
10. Abdoli S, Ashktorab T, Ahmadi F, Parvizy S, Dunning T,. Religion, faith and the empowerment process: stories of Iranian people with diabetes. Int J Nurs Pract 2011; 17: 289-98.
11. Asche C, LaFleur J, Conner C,. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther 2011; 33: 74-109.
12. Society for Endocrinology, Metabolism and Diabetes of South Africa. Type 2 guidelines. http://www.semdsa.org.za/B-Clinical.asp (accessed May 2013).
13. Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009; 32: 193-203.
14. Inzucchi SE, Bergenstal RM, Buse JB, et al. American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycaemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-79.
15. International Diabetes Federation. Global Guideline for Type 2 Diabetes. http://www.idf.org/global-guideline-type-2-diabetes-2012 (accessed May 2012).
16. International Diabetes Federation. Global guideline for type 2 diabetes. http://www.idf.org/global-guideline-type-2-diabetes-2005 (accessed May 2013).
17. Sharaf F,. Impact of health education on compliance among patients of chronic diseases in Al Qassim, Saudi Arabia. Int J Health Sci (Qassim) 2010; 4: 139-48.
18. Al-Saeedi M, Elzubier AG, Bahnassy AA, Al-Dawood KM,. Treatment-related misconceptions among diabetic patients in Western Saudi Arabia. Saudi Med J 2002; 23: 1243-6.
19. Hammer JS, Jackson WG,; World Bank Development Research Group. The design of incentives for healthcare providers in developing countries. Contracts, competition and cost control. Policy research working paper 2547. http://www-wds.worldbank.org/external/default/WDSContentServer/IW3P/IB/2001/03/ 20/000094946-01030305572310/Rendered/PDF/multi-page.pdf (accessed May 2013).
20. World Health Organisation Regional Health Systems Observatory-EMRO. Health System Profile. Egypt, 2006. http://gis.emro.who.int/ HealthSystemObservatory/PDF/Egypt/Full Profile.pdf (accessed May 2013).
21. Zolfaghari M, Mousavifar SA, Pedram S, Haghani H,. The impact of nurse short message services and telephone follow-ups on diabetic adherence: which one is more effective? J Clin Nurs 2012; 21: 1922-31.
22. Delamater AM,. Improving patient adherence. Clin Diabetes 2006; 24: 71-7.